Gliwice, Poland

Cecylia Kwasniewska-Rokicinska


Average Co-Inventor Count = 7.5

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 1979

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Cecylia Kwasniewska-Rokicinska

Introduction

Cecylia Kwasniewska-Rokicinska is a notable inventor based in Gliwice, Poland. She has made significant contributions to the field of chemistry, particularly in the development of anti-neoplastic agents. With a total of two patents to her name, her work has the potential to impact cancer treatment.

Latest Patents

Cecylia's latest patents include the invention of 1-Nitro-9-dialkylaminoisoalkylaminoacridines or their salts. These compounds are characterized by a specific formula where R represents lower alkyl groups such as methyl or ethyl. The invention describes their preparation and highlights their usefulness as anti-neoplastic agents. Additionally, she has patented 1-Nitro-9-alkylaminoalkylaminoacridines and their salts, which also exhibit anti-neoplastic activity. These compounds are defined by a formula where R can be various alkyl groups, and the salts are derived from mineral or organic acids.

Career Highlights

Cecylia Kwasniewska-Rokicinska is affiliated with the Gdansk University of Technology, where she continues her research and development in the field of chemistry. Her work is recognized for its innovative approach to creating compounds that can aid in cancer treatment.

Collaborations

Cecylia has collaborated with notable colleagues such as Andrzej Ledochowski and Jerzy Gieldanowski. Their combined expertise has contributed to the advancement of her research and the successful development of her patented compounds.

Conclusion

Cecylia Kwasniewska-Rokicinska's contributions to the field of anti-neoplastic agents through her innovative patents demonstrate her significant role as an inventor. Her work continues to pave the way for advancements in cancer treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…